Status:
COMPLETED
Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses
Lead Sponsor:
LEO Pharma
Collaborating Sponsors:
Bayer
Conditions:
Skin Mycoses
Eligibility:
All Genders
Brief Summary
An assessment of the efficacy and safety of Travogen cream and Travocort cream in the treatment of local skin mycoses
Eligibility Criteria
Inclusion
- Diagnosis of skin mycosis
Exclusion
- Allergies to study medication
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT00722189
Start Date
July 1 2008
End Date
February 1 2009
Last Update
June 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kashkin Clinical Research Mycological Institute
Saint Petersburg, Russia